ID   KY-ADR2
AC   CVCL_Z940
DR   cancercelllines; CVCL_Z940
DR   Wikidata; Q54900769
RX   PubMed=7934146;
RX   PubMed=12716468;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7463; Acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1346 ! KY821
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 12
//
RX   PubMed=7934146; DOI=10.1016/0145-2126(94)90071-X;
RA   Fukuda T., Kakihara T., Kamishima T., Ohnishi Y., Naito M., Kishi K.,
RA   Shibata A., Tsuruo T.;
RT   "Characterization of newly established adriamycin resistant human
RT   leukemic cell lines (KY-ADR1 and KY-ADR2).";
RL   Leuk. Res. 18:709-715(1994).
//
RX   PubMed=12716468; DOI=10.1111/j.1349-7006.2002.tb01336.x;
RA   Shimizu H., Fukuda T., Ghazizadeh M., Nagashima M., Kawanami O.,
RA   Suzuki T.;
RT   "Molecular cytogenetic characterization of drug-resistant leukemia
RT   cell lines by comparative genomic hybridization and fluorescence in
RT   situ hybridization.";
RL   Jpn. J. Cancer Res. 93:902-910(2002).
//